{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:19:06Z","timestamp":1780924746556,"version":"3.54.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.3816\/clm.2003.n.016","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:10:05Z","timestamp":1221095405000},"page":"86-92","source":"Crossref","is-referenced-by-count":35,"title":["Acquired Immunodeficiency Syndrome\u2013Related Lymphoma in the Era of Highly Active Antiretroviral Therapy"],"prefix":"10.3816","volume":"4","author":[{"given":"Christina","family":"Thirlwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debashis","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Stebbing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2003.n.016_bib1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJM198408303110904","article-title":"Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome","volume":"311","author":"Ziegler","year":"1984","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2003.n.016_bib2","series-title":"Report on the global HIV\/AIDS epidemic","author":"Joint United Nations Programme on HIV\/AIDS","year":"2002"},{"key":"10.3816\/CLM.2003.n.016_bib3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2003.n.016_bib4","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.285.13.1736","article-title":"Association of cancer with AIDSrelated immunosuppression in adults","volume":"285","author":"Frisch","year":"2001","journal-title":"JAMA"},{"key":"10.3816\/CLM.2003.n.016_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00002030-200302140-00011","article-title":"HIV-related lung cancer in the era of highly active antiretroviral therapy","volume":"17","author":"Bower","year":"2003","journal-title":"AIDS"},{"key":"10.3816\/CLM.2003.n.016_bib6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0140-6736(91)92513-2","article-title":"AIDS-associated non-Hodgkin lymphoma","volume":"337","author":"Beral","year":"1991","journal-title":"Lancet"},{"key":"10.3816\/CLM.2003.n.016_bib7","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/(SICI)1097-0215(19961211)68:6<754::AID-IJC11>3.0.CO;2-0","article-title":"Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS. Multistate AIDS\/Cancer Match Study Group","volume":"68","author":"Bigger","year":"1996","journal-title":"Int J Cancer"},{"key":"10.3816\/CLM.2003.n.016_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bmj.319.7201.23","article-title":"Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study","volume":"319","author":"Ledergerber","year":"1999","journal-title":"Br Med J"},{"key":"10.3816\/CLM.2003.n.016_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/108729102317330445","article-title":"AIDS-related primary brain lymphoma in Michigan, January 1990 to December 2000","volume":"16","author":"Inungu","year":"2002","journal-title":"AIDS Patient Care STDS"},{"key":"10.3816\/CLM.2003.n.016_bib10","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1182\/blood.V98.12.3406","article-title":"Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy","volume":"98","author":"Kirk","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.n.016_bib11","doi-asserted-by":"crossref","unstructured":"Buchbinder SP, Vittinghoff E, Colfax G, et al. Declines in AIDS incidence associated with highly active anti-retroviral therapy (HAART) are not reflected in KS and lymphoma incidence. In: Proceedings of the 2nd National AIDS Malignancy Conference; Bethesda, MD; 1998:S7.","DOI":"10.1097\/00042560-199804010-00128"},{"issue":"suppl 1","key":"10.3816\/CLM.2003.n.016_bib12","first-page":"34","article-title":"Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphoma among HIV-1 infected individuals","volume":"21","author":"Jacobson","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"suppl 1","key":"10.3816\/CLM.2003.n.016_bib13","first-page":"31","article-title":"Kaposi's sarcoma and non- Hodgkin's lymphoma incidence and trends in AIDS Clinical Trial Group study participants","volume":"21","author":"Rabkin","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.3816\/CLM.2003.n.016_bib14","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/00002030-200209060-00014","article-title":"The incidence of lymphoma in the UK haemophilia population between 1978 and 1999","volume":"16","author":"Wilde","year":"2002","journal-title":"AIDS"},{"key":"10.3816\/CLM.2003.n.016_bib15","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/jnci\/92.22.1823","article-title":"Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virusinfected adults","volume":"92","author":"International collaboration on HIV and cancer","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CLM.2003.n.016_bib16","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(97)09028-4","article-title":"Spectrum of AIDS-associated malignant disorders","volume":"351","author":"Goedert","year":"1998","journal-title":"Lancet"},{"key":"10.3816\/CLM.2003.n.016_bib17","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood.V93.6.1838.406k39_1838_1842","article-title":"Chemokine and chemokine receptor gene variants and risk of non-Hodgkin's lymphoma in human immunodeficiency virus 1 infected individuals","volume":"93","author":"Rabkin","year":"1999","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.n.016_bib18","first-page":"3561","article-title":"Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-delta32 mutation","volume":"59","author":"Dean","year":"1999","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2003.n.016_bib19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1086\/313761","article-title":"Value of long-term administration of acyclovir and similar agents for protecting against AIDS-related lymphoma: casecontrol and historical cohort studies","volume":"30","author":"Fong","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.3816\/CLM.2003.n.016_bib20","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V96.8.2730","article-title":"Changes in Aquired Immunodeficiency Syndrome-related lymphoma since the introduction of highly active antiretroviral therapy","volume":"96","author":"Matthews","year":"2000","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.n.016_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00002030-200001280-00008","article-title":"B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS","volume":"14","author":"Grulich","year":"2000","journal-title":"AIDS"},{"key":"10.3816\/CLM.2003.n.016_bib22","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00126334-200208150-00003","article-title":"Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival","volume":"30","author":"Gerard","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.3816\/CLM.2003.n.016_bib23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/blood.V76.2.317.317","article-title":"Human immunodeficiency virus infection of human bone marrow stromal fibroblasts","volume":"76","author":"Scadden","year":"1992","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.n.016_bib24","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1182\/blood.V87.3.919.bloodjournal873919","article-title":"Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors","volume":"87","author":"Moses","year":"1996","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.n.016_bib25","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/00002030-200304110-00011","article-title":"Leptomeningeal disease in AIDS related non-Hodgkin's lymphoma","volume":"17","author":"Sarker","year":"2003","journal-title":"AIDS"},{"key":"10.3816\/CLM.2003.n.016_bib26","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1840::AID-CNCR28>3.0.CO;2-C","article-title":"Patterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-hodgkin lymphoma","volume":"86","author":"Desai","year":"1999","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.016_bib27","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199706053362304","article-title":"Low dose compared with standard dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection","volume":"336","author":"Kaplan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2003.n.016_bib28","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2000.18.19.3325","article-title":"Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas","volume":"18","author":"Cingolani","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.016_bib29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/1097-0142(19800201)45:3<545::AID-CNCR2820450322>3.0.CO;2-6","article-title":"CNS involvement in the non- Hodgkin's lymphomas","volume":"45","author":"Levitt","year":"1980","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.016_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jama.1991.03470010088036","article-title":"Low dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDSrelated lymphoma","volume":"266","author":"Levine","year":"1991","journal-title":"JAMA"},{"issue":"suppl","key":"10.3816\/CLM.2003.n.016_bib31","first-page":"A12","article-title":"Dose adjusted treatment in AIDS-related lymphoma","volume":"23","author":"Tirelli","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.3816\/CLM.2003.n.016_bib32","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jama.1989.03420050069041","article-title":"AIDS-associated non-Hodgkin's lymphoma in San Francisco","volume":"261","author":"Kaplan","year":"1989","journal-title":"JAMA"},{"key":"10.3816\/CLM.2003.n.016_bib33","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1200\/JCO.1987.5.9.1322","article-title":"AIDS-related malignant lymphoma: results of prospective treatment trials","volume":"5","author":"Gill","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.016_bib34","doi-asserted-by":"crossref","first-page":"744","DOI":"10.7326\/0003-4819-108-5-744","article-title":"Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): The New York University Medical Center experience with 109 patients","volume":"108","author":"Knowles","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.3816\/CLM.2003.n.016_bib35","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/1097-0142(19880601)61:11<2325::AID-CNCR2820611130>3.0.CO;2-0","article-title":"AIDS-related lymphoid neoplasia. The Memorial Hospital Experience","volume":"61","author":"Lowenthal","year":"1988","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.016_bib36","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0002-9343(93)90259-R","article-title":"High-dose chemotherapy (LNH84) for HIV-associated non-Hodgkin's lymphoma","volume":"95","author":"Gisselbrecht","year":"1993","journal-title":"Am J Med"},{"key":"10.3816\/CLM.2003.n.016_bib37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/1096-8652(200103)66:3<178::AID-AJH1042>3.0.CO;2-H","article-title":"Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin's lymphoma: evaluation of the role of G-CSF; quality-of-life analysis and long-term follow-up","volume":"66","author":"Remick","year":"2001","journal-title":"Am J Hematol"},{"key":"10.3816\/CLM.2003.n.016_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s002770050464","article-title":"Treatment of acquired immunodeficiency syndrome-related lymphoma with a standard chemotherapy regimen","volume":"78","author":"Aviles","year":"1999","journal-title":"Ann Hematol"},{"key":"10.3816\/CLM.2003.n.016_bib39","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1023\/A:1008484522952","article-title":"Treatment of AIDS-related non- Hodgkin's lymphoma with chemotherapy (CNOP) and r-hu-G-CSF: clinical outcome and effect on HIV-1 viral load","volume":"9","author":"Kersten","year":"1998","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2003.n.016_bib40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/10428199809058386","article-title":"HIV-related non-Hodgkin's lymphoma: CHOP induction therapy and interferon-alpha-2b\/zidovudine maintenance therapy","volume":"29","author":"Weiss","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2003.n.016_bib41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1445-5994.1998.tb04455.x","article-title":"Long term follow-up of CEOP in the treatment of HIV related non-Hodgkin's lymphoma (NHL)","volume":"28","author":"Davis","year":"1998","journal-title":"Aust N Z J Med"},{"key":"10.3816\/CLM.2003.n.016_bib42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0609.1995.tb01771.x","article-title":"Intensive treatment of AIDSrelated non-Hodgkin's lymphomas with the MACOP-B protocol","volume":"54","author":"Schurmann","year":"1995","journal-title":"Eur J Haematol"},{"key":"10.3816\/CLM.2003.n.016_bib43","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/oxfordjournals.annonc.a058108","article-title":"Prospective study with combined low-dose chemotherapy and zidovudine in 37 patients with poorprognosis AIDS-related non-Hodgkin's lymphoma. French-Italian Cooperative Study Group","volume":"3","author":"Tirelli","year":"1992","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2003.n.016_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/10428199209054907","article-title":"Treatment of AIDS-related non-Hodgkin's lymphoma with a twelve week chemotherapy program","volume":"8","author":"Sawka","year":"1992","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2003.n.016_bib45","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/oxfordjournals.annonc.a059067","article-title":"Chemotherapy combined with zidovudine and GM-CSF in human immunodeficiency virus-related non- Hodgkin's lymphoma","volume":"6","author":"Gabarre","year":"1995","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2003.n.016_bib46","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1365-2141.2001.02656.x","article-title":"Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone","volume":"112","author":"Navarro","year":"2001","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2003.n.016_bib47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1097-0142(20010101)91:1<155::AID-CNCR20>3.0.CO;2-B","article-title":"Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virusrelated, non-Hodgkin lymphoma","volume":"91","author":"Vaccher","year":"2001","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.016_bib48","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00002030-200108170-00005","article-title":"Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy","volume":"15","author":"Antinori","year":"2001","journal-title":"AIDS"},{"key":"10.3816\/CLM.2003.n.016_bib49","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood.V98.8.2339","article-title":"Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy","volume":"98","author":"Besson","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.n.016_bib50","first-page":"17a","article-title":"Changes in AIDS related lymphoma (ARL) in the era of highly active antiretroviral therapy (HAART)","volume":"19","author":"Bower","year":"2000","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLM.2003.n.016_bib51","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/10428190109057959","article-title":"Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART)","volume":"41","author":"Chow","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2003.n.016_bib52","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2001.19.8.2171","article-title":"Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy","volume":"19","author":"Ratner","year":"2001","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"10.3816\/CLM.2003.n.016_bib53","first-page":"470a","article-title":"CHOP chemotherapy plus rituximab in HIV patients with high grade lymphoma- results of an ANRS trial","volume":"100","author":"Boue","year":"2002","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.n.016_bib54","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0959-8049(99)00260-9","article-title":"Weekly alternating combination chemotherapy for good prognosis AIDS related lymphoma","volume":"36","author":"Bower","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.3816\/CLM.2003.n.016_bib55","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/cncr.10365","article-title":"Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma\/leukemia","volume":"94","author":"Cortes","year":"2002","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.016_bib56","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/10428190009053542","article-title":"Intensive chemotherapy (LNHIV-91 regimen) and G-CSF for HIV associated non-Hodgkin's lymphoma","volume":"39","author":"Oksenhendler","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2003.n.016_bib57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-3-642-56352-2_18","article-title":"Infusional CDE with rituximab for the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: preliminary results of a phase I\/II study","volume":"159","author":"Tirelli","year":"2002","journal-title":"Recent Results Cancer Res"},{"key":"10.3816\/CLM.2003.n.016_bib58","first-page":"1051","article-title":"High dose of idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin's lymphoma patients: a pilot study","volume":"86","author":"Gastaldi","year":"2001","journal-title":"Haematologica"},{"key":"10.3816\/CLM.2003.n.016_bib59","first-page":"10a","article-title":"Dose-adjusted EPOCH chemotherapy in previously untreated HIV-associated non-Hodgkin's lymphoma","volume":"18","author":"Little","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLM.2003.n.016_bib60","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1182\/blood.V81.10.2810.2810","article-title":"Infusional cyclophosphamide, doxorubicin and etoposide in HIV and HTLV-1 related non Hodgkin's lymphoma","volume":"81","author":"Sparano","year":"1993","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.n.016_bib61","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1200\/JCO.1996.14.11.3026","article-title":"Pilot trial of infusional cyclophosphamide, doxorubicin and etoposide plus didanosine and filgrastim in patients with HIV associated non-Hodgkin's lymphoma","volume":"14","author":"Sparano","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.016_bib62","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/blood-2002-11-3589","article-title":"Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology","volume":"101","author":"Little","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.n.016_bib63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF02787345","article-title":"Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin and etoposide in patients with HIV-associated non-Hodgkin's lymphoma","volume":"15","author":"Sparano","year":"1998","journal-title":"Med Oncol"},{"key":"10.3816\/CLM.2003.n.016_bib64","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/10428199409049677","article-title":"Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a followup report of a highly active regimen","volume":"14","author":"Sparano","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2003.n.016_bib65","first-page":"12a","article-title":"Phase II trial of infusional cyclophosphamide, doxorubicin and etoposide (CDE) in HIV-associated non- Hodgkin's lymphoma: An Eastern Cooperative Oncology Group Trial (E1494)","volume":"18","author":"Sparano","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLM.2003.n.016_bib66","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1089\/aid.1996.12.1703","article-title":"The effects of antineoplastic chemotherapy on HIV disease","volume":"12","author":"Zanussi","year":"1996","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.3816\/CLM.2003.n.016_bib67","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00002030-200203080-00003","article-title":"Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma","volume":"16","author":"Powles","year":"2002","journal-title":"AIDS"},{"key":"10.3816\/CLM.2003.n.016_bib68","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1182\/blood.V90.9.3789","article-title":"Constraints on CD4 recovery post chemotherapy in adults","volume":"90","author":"Hakim","year":"1997","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.n.016_bib69","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1634\/stemcells.18-1-10","article-title":"T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review","volume":"18","author":"Mackall","year":"2000","journal-title":"Stem Cells"},{"issue":"RR-8","key":"10.3816\/CLM.2003.n.016_bib70","first-page":"1","article-title":"Guidelines for preventing opportunistic infections among HIV-infected persons\u20142002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America","volume":"51","author":"Kaplan","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"10.3816\/CLM.2003.n.016_bib71","unstructured":"Thirlwell C, Stebbing J, Nelson M, et al. CDE chemotherapy plus HAART for AIDS related non-Hodgkin's lymphoma. In: Proceedings of 6th International Congress on Drug Therapy in HIV Infection, 2002. vol. 94."},{"key":"10.3816\/CLM.2003.n.016_bib72","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/1097-0142(19911201)68:11<2466::AID-CNCR2820681124>3.0.CO;2-G","article-title":"Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival","volume":"68","author":"Levine","year":"1991","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.016_bib73","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2391::AID-CNCR29>3.0.CO;2-0","article-title":"The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related non-Hodgkin lymphoma","volume":"86","author":"Rossi","year":"1999","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.016_bib74","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1200\/JCO.1998.16.11.3601","article-title":"Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142\u2013low-dose versus standard- dose m-BACOD plus granulocyte-macrophage colony-stimulating factor","volume":"16","author":"Straus","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2003.n.016_bib75","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.bmt.1703348","article-title":"High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier","volume":"29","author":"Kentos","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.3816\/CLM.2003.n.016_bib76","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1182\/blood.V98.13.3857","article-title":"Autologous stem cell transplantation for HIV-associated lymphoma","volume":"98","author":"Krishnan","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2003.n.016_bib77","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/1097-0142(20000801)89:3<680::AID-CNCR25>3.0.CO;2-W","article-title":"High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy","volume":"89","author":"Molina","year":"2000","journal-title":"Cancer"},{"key":"10.3816\/CLM.2003.n.016_bib78","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(00)02041-9","article-title":"High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma","volume":"355","author":"Gabarre","year":"2000","journal-title":"Lancet"},{"key":"10.3816\/CLM.2003.n.016_bib79","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1046\/j.1365-2141.1999.01422.x","article-title":"Syngeneic stem cell transplantation for HIV-related lymphoma","volume":"105","author":"Campbell","year":"1999","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2003.n.016_bib80","first-page":"1195","article-title":"Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma","volume":"18","author":"Gabarre","year":"1996","journal-title":"Bone Marrow Transplant"}],"container-title":["Clinical Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152696551170015X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152696551170015X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T06:09:16Z","timestamp":1588918156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152696551170015X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["S152696551170015X"],"URL":"https:\/\/doi.org\/10.3816\/clm.2003.n.016","relation":{},"ISSN":["1526-9655"],"issn-type":[{"value":"1526-9655","type":"print"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}